ACSL3 has been documented to impede ferroptosis by promoting monounsaturated fatty acids and diminishing polyunsaturated fatty acid peroxidation (Cao et al., 2025); however, its precise function in HCC is yet to be elucidated. This evidence concerns the gene ACSL3 and hepatocellular carcinoma.